Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Influence of Rifampin on Daptomycin PK
NCT02097953Phase 1Completed
- Sponsor
- University of Utah
- Start
- May 2014
- Primary completion
- Jun 2015
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of daptomycin in bacterial infection, sponsored by University of Utah. Primary endpoints: Daptomycin total, renal, and non-renal clearance at 14 days, Daptomycin Volume of Distribution at 14 days and 6 more. Started May 2014; status: completed.
02
Drugs
daptomycin
03
Conditions
bacterial infection
Beyond the preview
Go deeper on NCT02097953.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02097953.